Operating
Change in Other Assets
Pfizer Change in Other Assets remained flat by 0.0% to -$322.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 61.9%, from -$845.00M to -$322.25M. Over 4 years (FY 2021 to FY 2025), Change in Other Assets shows a downward trend with a 5.1% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
Large swings are usually related to the timing of prepayments for services or long-term supply agreements.
Detailed definition
This captures the net change in miscellaneous operating assets not classified as receivables or inventory, such as prepa...
Peer comparison
This is typically a smaller component of cash flow for most large-cap technology firms unless they are securing long-term supply capacity.
Metric ID:
cf_change_in_other_assetsHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $1.06B | $4.51B | $663.00M | -$3.38B | -$1.29B |
| YoY Change | — | +326.3% | -85.3% | -609.8% | +61.9% |
Range-$3.38B – $4.51B
CAGR+5.1%
Avg YoY Growth-76.7%
Median YoY Growth-11.7%
Change in Other Assets at Other Companies
Frequently Asked Questions
- What is Pfizer's change in other assets?
- Pfizer (PFE) reported change in other assets of -$322.25M in Q4 2025.
- How has Pfizer's change in other assets changed year-over-year?
- Pfizer's change in other assets increased by 61.9% year-over-year, from -$845.00M to -$322.25M.
- What is the long-term trend for Pfizer's change in other assets?
- Over 4 years (2021 to 2025), Pfizer's change in other assets has grown at a 5.1% compound annual growth rate (CAGR), from $1.06B to -$1.29B.
- What does change in other assets mean?
- The change in various other business assets like prepayments or miscellaneous deposits.